News - Thallion Pharmaceuticals, Antibiotics and Infectious diseases

Filter

Popular Filters

Termination of Shigamabs deal with LFB Biotech leads Thallion to review options

21-02-2013

Canada-based Thallion Pharmaceuticals (TSX VENTURE: TLN) and LFB Biotechnologies of France have terminated…

Antibiotics and Infectious diseasesBiotechnologyLFB BiotechnologiesLicensingShigamabsThallion Pharmaceuticals

Back to top